m6A Target Gene Information
General Information of the m6A Target Gene (ID: M6ATAR00457)
Full List of m6A Methylation Regulator of This Target Gene and Corresponding Disease/Drug Response(s)
ATP2A2
can be regulated by the following regulator(s), and cause disease/drug response(s). You can browse detail information of regulator(s) or disease/drug response(s).
Browse Regulator
Browse Disease
Fat mass and obesity-associated protein (FTO) [ERASER]
Representative RNA-seq result indicating the expression of this target gene regulated by FTO | ||
Cell Line | NB4 cell line | Homo sapiens |
Treatment: shFTO NB4 cells
Control: shNS NB4 cells
|
GSE103494 | |
Regulation |
|
logFC: 5.91E-01 p-value: 1.58E-02 |
More Results | Click to View More RNA-seq Results |
In total 1 item(s) under this regulator | ||||
Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene | [1] | |||
Response Summary | FTO modification of N6 -methyladenosine is associated with myocardial cell energy metabolism disorder. FTO reduced the m6A level of Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2a/ATP2A2) mRNA through demethylation, thus promoting SERCA2a expression, maintaining calcium homeostasis, and improving energy metabolism of H/R cardiomyocytes. | |||
Target Regulation | Up regulation | |||
Responsed Disease | Energy metabolism disorder | ICD-11: 5C53 | ||
Cell Process | Energy metabolism | |||
Cell apoptosis | ||||
In-vitro Model | AC16 [Human hybrid cardiomyocyte] | Normal | Homo sapiens | CVCL_4U18 |
Energy metabolism disorder [ICD-11: 5C53]
In total 1 item(s) under this disease | ||||
Experiment 1 Reporting the m6A-centered Disease Response | [1] | |||
Response Summary | FTO modification of N6 -methyladenosine is associated with myocardial cell energy metabolism disorder. FTO reduced the m6A level of Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2a/ATP2A2) mRNA through demethylation, thus promoting SERCA2a expression, maintaining calcium homeostasis, and improving energy metabolism of H/R cardiomyocytes. | |||
Responsed Disease | Energy metabolism disorder [ICD-11: 5C53] | |||
Target Regulator | Fat mass and obesity-associated protein (FTO) | ERASER | ||
Target Regulation | Up regulation | |||
Cell Process | Energy metabolism | |||
Cell apoptosis | ||||
In-vitro Model | AC16 [Human hybrid cardiomyocyte] | Normal | Homo sapiens | CVCL_4U18 |